X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
pharmacology & pharmacy (5) 5
index medicus (4) 4
biomedicine (3) 3
drug interactions (3) 3
drugs (3) 3
hiv (3) 3
hiv infections - drug therapy (3) 3
male (3) 3
pharmacology/toxicology (3) 3
acquired immune deficiency syndrome (2) 2
acquired immune deficiency syndrome--aids (2) 2
antiretroviral agents (2) 2
antiviral agents (2) 2
biomaterials (2) 2
chromatography, high pressure liquid - methods (2) 2
colitis (2) 2
drug administration schedule (2) 2
drug monitoring (2) 2
efficacy (2) 2
high performance liquid chromatography (2) 2
hiv patients (2) 2
hplc (2) 2
hplc-uv (2) 2
human immunodeficiency virus (2) 2
human immunodeficiency virus--hiv (2) 2
medical laboratory technology (2) 2
medicine (2) 2
middle aged (2) 2
neurosciences (2) 2
performance liquid-chromatography (2) 2
review (2) 2
ritonavir (2) 2
side effects (2) 2
toxicology (2) 2
3d printing (1) 1
active metabolite (1) 1
adult (1) 1
agents (1) 1
agreement (1) 1
aids (1) 1
all terrain vehicles (1) 1
amprenavir (1) 1
analysis (1) 1
analytical methods (1) 1
anilides - therapeutic use (1) 1
anti-bacterial agents - administration & dosage (1) 1
anti-bacterial agents - pharmacokinetics (1) 1
anti-bacterial agents - therapeutic use (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - pharmacokinetics (1) 1
anti-retroviral agents - administration & dosage (1) 1
anti-retroviral agents - pharmacokinetics (1) 1
antiepileptic drugs (1) 1
antiretroviral (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy (1) 1
antiretroviral therapy, highly active (1) 1
antiretrovirals (1) 1
antiviral agents - blood (1) 1
antiviral agents - pharmacokinetics (1) 1
antiviral agents - therapeutic use (1) 1
arteries (1) 1
assay (1) 1
atazanavir sulfate (1) 1
atazanavir sulfate - administration & dosage (1) 1
atazanavir sulfate - adverse effects (1) 1
atazanavir sulfate - blood (1) 1
atazanavir sulfate - pharmacokinetics (1) 1
bilirubin (1) 1
bioanalytical method validation (1) 1
biochemistry, genetics and molecular biology (1) 1
bioengineering (1) 1
biological properties (1) 1
biological samples (1) 1
biomedical materials (1) 1
blood cells (1) 1
cancer (1) 1
carbamates - therapeutic use (1) 1
cardiovascular diseases (1) 1
care and treatment (1) 1
chromatography (1) 1
clinical trials (1) 1
colitis, colon drug delivery, personalized medicine, three-dimensional printing (1) 1
colon cancer (1) 1
colon drug delivery (1) 1
comedication (1) 1
complexity (1) 1
complications (1) 1
coronary artery (1) 1
cutaneous fistula - drug therapy (1) 1
cutaneous fistula - microbiology (1) 1
detectors (1) 1
digestive system diseases (1) 1
disease activity index (1) 1
dolutegravir (1) 1
dosage (1) 1
dosage and administration (1) 1
drug delivery systems (1) 1
drug development (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0123670 - e0123670
Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia,... 
UNBOOSTED ATAZANAVIR | BILIRUBIN | HYPERBILIRUBINEMIA | EFFICACY | PHARMACOKINETICS | TOLERABILITY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | RENAL STONES | POLYMORPHISM | RITONAVIR-BOOSTED ATAZANAVIR | Nephrolithiasis - chemically induced | Atazanavir Sulfate - administration & dosage | Humans | Middle Aged | Male | Atazanavir Sulfate - adverse effects | Atazanavir Sulfate - pharmacokinetics | Drug Dosage Calculations | Dyslipidemias - blood | HIV-1 - physiology | Ritonavir - adverse effects | HIV Protease Inhibitors - pharmacokinetics | Hyperbilirubinemia - chemically induced | Adult | Female | Hyperbilirubinemia - physiopathology | Nephrolithiasis - physiopathology | Dyslipidemias - diagnosis | HIV Protease Inhibitors - adverse effects | HIV Protease Inhibitors - blood | Atazanavir Sulfate - blood | Drug Administration Schedule | Hyperbilirubinemia - diagnosis | HIV-1 - drug effects | HIV Infections - virology | Nephrolithiasis - blood | HIV Protease Inhibitors - administration & dosage | Nephrolithiasis - diagnosis | Antiretroviral Therapy, Highly Active | Hyperbilirubinemia - blood | Dyslipidemias - chemically induced | HIV Infections - drug therapy | Drug Monitoring | Viral Load - drug effects | Dyslipidemias - physiopathology | Highly active antiretroviral therapy | HIV patients | HIV (Viruses) | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Toxicity | Ritonavir | Complications | Dyslipidemia | Lipids | Nephrolithiasis | Dosage | Patients | Side effects | Hyperbilirubinemia | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Antiretroviral agents | Human immunodeficiency virus--HIV | All terrain vehicles | Index Medicus | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Journal Article
World Journal of Clinical Oncology, ISSN 2218-4333, 02/2017, Volume 8, Issue 1, pp. 21 - 36
Current research in oncology deploys methods that rely principally on two-dimensional (2D) mono-cell cultures and animal models. Although these methodologies... 
In vivo | Three-dimensional bio-printing | In vitro | Biomaterials | Cancer | Review
Journal Article
Current cardiology reviews, ISSN 1573-403X, 01/2019, Volume 15, Issue 3, p. 188
Three-dimensional (3D) printing, also known as additive manufacturing, was developed originally for engineering applications. Since its early advancements,... 
Printing | Bioengineering | Hydrogels | Tissue engineering | Medical innovations | Organs | Coronary artery | Printers | Drug development | Human tissues | Arteries | Complexity | Biomaterials | Fabrication | Engineering | Biomedical materials | Three dimensional printing | Cardiovascular diseases | Heart diseases | Material properties
Journal Article
International journal of pharmaceutical investigation, ISSN 2230-973X, 04/2017, Volume 7, Issue 2, pp. 47 - 59
Orally administered solid dosage forms currently dominate over all other dosage forms and routes of administrations. However, human gastrointestinal tract... 
Drugs | Proteins | Care and treatment | Drug delivery systems | Colon cancer | Gastrointestinal system | 3D printing | Ulcerative colitis | Vehicles | Review | Colitis | colon drug delivery | three-dimensional printing | personalized medicine
Journal Article
Inflammation, ISSN 0360-3997, 12/2019, Volume 42, Issue 6, pp. 2032 - 2036
Hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) inhibitors are shown to be protective in several models of inflammatory bowel disease (IBD). However,... 
Pathology | Biomedicine | Immunology | colitis | prolyl hydroxylases | Rheumatology | disease activity index | Internal Medicine | Pharmacology/Toxicology | inflammatory bowel disease
Journal Article
PLoS ONE, 04/2015, Volume 10, Issue 4
Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia,... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.